Floridienne SA 2025 AR2
The report highlights the performance of Floridienne Group for the fiscal year 2025, during which the group achieved a turnover of €725.9 million, driven by its Life Sciences Division. The group continued to expand its sustainable activities, notably through BioFirst's acquisition of Bugs for Bugs and Natix's acquisition of Terhormon. Despite challenges such as hyperinflation in Turkey and unfavorable exchange rates, the group maintained solid operating fundamentals. Floridienne remains committed to sustainable development, integrating ESG criteria across its Life Sciences, Food, and Recycling divisions.
Company: Floridienne SA
Sector: Manufacturing
Country: Belgium
Year: 2025
Type: AR2
Pages: 78
Back to company
Floridienne SA
Annual Report
The report highlights the performance of Floridienne Group for the fiscal year 2025, during which the group achieved a turnover of €725.9 million, driven by its Life Sciences Division. The group continued to expand its sustainable activities, notably through BioFirst's acquisition of Bugs for Bugs and Natix's acquisition of Terhormon. Despite challenges such as hyperinflation in Turkey and unfavorable exchange rates, the group maintained solid operating fundamentals. Floridienne remains committed to sustainable development, integrating ESG criteria across its Life Sciences, Food, and Recycling divisions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees